Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction

Clinical Science

Volumn 112, Issue 7-8, 2007, Pages 411-416

  Maznyczka, Annette ^a   Mangino, Massimo ^a   Whittaker, Andrew ^a   Braund, Peter ^a   Palmer, Tom ^b   Tobin, Martin ^b   Goodall, Alison H ^a   Bradding, Peter ^c   Samani, Nilesh J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Departments of Health Sciences and Genetics   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Arachidonate 5 lipoxygenase activating protein (ALOX5AP); Cardiovascular risk; Leukotriene; Myocardial infarction; Single nucleotide polymorphism

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CALCIMYCIN; CALCIUM IONOPHORE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE; CARRIER PROTEIN; IONOPHORE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA SCREENING; FEMALE; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HETEROZYGOTE DETECTION; HUMAN; HUMAN EXPERIMENT; MALE; NEUTROPHIL; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; METABOLISM; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULATION;

ANALYSIS OF VARIANCE; ARACHIDONATE 5-LIPOXYGENASE; CALCIMYCIN; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; IONOPHORES; LEUKOTRIENE B4; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STIMULATION, CHEMICAL;

EID: 34247141061     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060271     Document Type: Article

References (24)

1. Boersma, E., Mercado, N., Poldermans, D., Gardien, M., Vos, J. and Simoons, M. L. (2003) Acute myocardial infarction. Lancet 361, 847-858
2. Funk, C. D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875
3. Mehrabian, M., Allayee, H., Wong, J. et al. (2002) Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91, 120-126
4. Spanbroek, R., Gräbner, R., Lötzer, K. et al. (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 100, 1238-1243
5. Funk, C. D. (2005) Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat. Rev. Drug. Discovery 4, 664-672
6. Lynch, K. R., O'Neill, G. P., Liu, Q. et al. (1999) Characterisation of the human cysteinyl leukotriene cysLT1 receptor. Nature 399, 789-793
7. Heise, C. E., O'Dowd, B. F., Figueroa, D. J. et al. (2000) Characterisation of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275, 30531-30536
8. 4 that mediates chemotaxis. Nature 387, 620-624
9. 4 receptor BLT2: a new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192, 421-432
10. Reference deleted
11. Kennedy, B. P., Diehl, R. E., Boie, Y., Adam, M. and Dixon, R. A. F. (1991) Gene characterisation and promoter analysis of the human 5-lipoxygenase activating protein (ALOX5AP). J. Biol. Chem. 266, 8511-8516
12. Helgadottir, A., Manolescu, A., Thorleifsson, G. et al. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233-239
13. Tobin, M. D., Raleigh, S. M., Newhouse, S. et al. (2005) Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 112, 3423-3429
14. English, D. and Andersen, B. R. (1974) Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of ficoll-hypaque. J. Immunol. Methods 5, 249-252
15. Abecasis, G. R., Cherny, S. S., Cookson, W. O. and Cardon, L. R. (2002) Merlin: rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30, 97-101
16. Reed, G. F., Lynn, F. and Meade, B. D. (2002) Use of coefficient of variation in assessing variability of quantitative assays. Clin. Diagn. Lab. Immunol. 9, 1235-1239
17. Cipollone, F., Mezzetti, A., Fazia, M. L. et al. (2005) Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler. Thromb. Vasc. Biol. 25, 1665-1670
18. Aiello, R. J., Bourassa, P. A., Lindsey, S., Weng, W., Freeman, A. and Showell, H. J. (2002) Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler. Thromb. Vasc. Biol. 22, 443-449
19. Helgadottir, A., Gretarsdottir, S., St Claire, D. et al. (2005) Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am. J. Hum. Genet. 76, 505-509
20. Lõnmussaar, E., Gschwendtner, A., Mueller, J. C. et al. (2005) ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 36, 731-736
21. Kajimoto, K., Shioji, K., Ishida, C. et al. (2005) Validation of the association between the gene encoding 5-lipoxygenase activating protein and myocardial infarction in a Japanese population. Circ. J. 69, 1029-1034
22. Hakonarson, H., Thorvaldsson, S., Helgadottir, A. et al. (2005) Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomised trial. JAMA, J. Am. Med. Assoc. 293, 2245-2256
23. Allen, S., Dashwood, M., Morrison, K. and Yacoub, M. (1998) Differential leukotriene constrictor response in human atherosclerotic coronary arteries. Circulation 97, 2406-2413
24. 4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge. Clin. Exp. Allergy 34, 1262-1269